Featured Clinical Leader Editorial
-
Can Virtual Trials Maintain Their Momentum After COVID?
9/17/2020
Prior to COVID-19, there were many discussions about how it might be possible to conduct virtual trials, using technology and innovative measures. Now that the pandemic has forced many trials into virtual settings, what will it take for the industry to fully implement a virtual approach beyond the pandemic?
-
Technology Advancements Spur Adoption Of Virtual Trials
1/17/2020
Patient recruitment and retention in clinical trials has long been an issue for pharma companies. This results in many trials being delayed and even canceled. One recent advancement that could help with both recruitment and retention is virtual (decentralized) trials.
-
What Exactly Is A Virtual Clinical Trial?
11/21/2019
Oracle Health Sciences and the CNS Summit have released a research report on the use of virtual components (patient-facing technologies) in clinical trials. The findings are the result of focus group interviews and supplementary research with key stakeholders involved with clinical trials.
-
Hybrid Decentralized Trials: Using Technology To Create More Patient-Centric Studies
11/5/2019
While it is not a new trend, the spotlight on digital innovation has grown brighter over the last year, with executives from all sides of the clinical research industry seeking technology solutions to improve the clinical trial experience for sites and patients alike. It was a recurring theme at this year’s Society for Clinical Research Sites (SCRS) Global Site Solutions Summit, with several sessions that addressed technological advancement and attendee feedback requesting more discussion on the topic at future Summits.
-
Less Cumbersome Trials Will Reduce Clinical Costs & Timelines
10/28/2019
Antony Loebel, president and CEO for Sunovion Pharmaceuticals, will be a featured speaker at the upcoming 2019 CNS Summit. In this Q&A, Loebel discusses CNS innovation, balancing the needs of clinical stakeholders, and the biggest changes we can expect over the next 10 years.
-
Innovation Will Overcome Time & Cost Challenges Of Clinical Trials
10/18/2019
Rob Scott, M.D., Chief Medical Officer and VP of Development for AbbVie, will be a featured speaker at the upcoming 2019 CNS Summit. In this Q&A, Scott discusses clinical innovation, patient voice, and the clinical challenges the pharmaceutical industry still needs to overcome.
-
Can Virtual Clinical Trials Democratize Medicine?
5/3/2019
There are over a quarter million active clinical trials registered with the FDA right now, up from just 1 percent of that figure at the turn of the century. It's a $65 billion industry – clinical trials alone, that is, and it's only going to get bigger.
-
Virtual Registries: How To Bring Patient-Centricity Into Clinical Research
11/27/2018
Our rapidly increasing genetic-level disease knowledge and exponential technology advances are changing the way we manage health. But we may never fully seize these opportunities if we limit our clinical research approach to past models. Changing societal attitudes around sharing personal data and new consumer technology make innovative study designs and operations possible. This includes new possibilities in designing and operationalizing patient registries by moving to “virtual” setups.